BioCeuticals Cognition Support 60 Tablets Joint Health Formula with Glucosamine Chondroitin and OptiMSM

Product Overview

BioCeuticals Cognition Support 60 Tablets is a premium joint health formulation developed by BioCeuticals, one of Australia's leading practitioner-only supplement companies. The product delivers clinically trialled doses of three key joint-support compounds: GlucosaGreen plant-based glucosamine hydrochloride (1500 mg), CS BioActive bovine-derived chondroitin sulfate (400 mg), and OptiMSM methylsulfonylmethane (500 mg). These ingredients work synergistically to support cartilage matrix synthesis, maintain synovial fluid viscosity, and modulate inflammatory mediators within the joint capsule.

The formulation is specifically designed to help relieve symptoms associated with mild knee osteoarthritis in adults, including joint pain, mild swelling, stiffness, reduced mobility, cartilage wear, and narrowing joint space. BioCeuticals manufactures this product under TGA-licensed Good Manufacturing Practice (GMP) conditions in Australia, ensuring pharmaceutical-grade quality control throughout the production process.

Specifications

Clinical Indications

• Symptomatic relief of mild knee osteoarthritis, including joint pain and stiffness
• Support for cartilage matrix synthesis and maintenance of articular cartilage integrity
• Reduction of mild joint swelling and improvement of joint mobility in osteoarthritic patients
• Support for synovial fluid composition and joint lubrication
• Nutritional support for connective tissue repair following joint injury or post-surgical rehabilitation

Frequently Asked Questions

Q: What distinguishes GlucosaGreen glucosamine from shellfish-derived glucosamine?
A: GlucosaGreen is a plant-based glucosamine hydrochloride produced via Aspergillus niger fermentation of non-GMO corn, making it suitable for individuals with shellfish allergies or those following vegetarian diets. Clinical studies published in the Journal of International Medical Research have demonstrated equivalent bioavailability and efficacy compared to traditional shellfish-derived glucosamine sulfate.

Q: How long should I take this product before expecting clinical improvement?
A: Clinical trials on glucosamine and chondroitin supplementation, including those reviewed by the Osteoarthritis Research Society International (OARSI), indicate that measurable symptom improvement typically occurs after 8 to 12 weeks of consistent daily supplementation. Short-term use of less than 4 weeks is unlikely to produce clinically significant joint symptom relief.

Q: Is this product registered with the Singapore Health Sciences Authority (HSA)?
A: This product is listed on the Australian Register of Therapeutic Goods (ARTG) under TGA regulation. In Singapore, health supplements containing glucosamine, chondroitin, and MSM are classified as health supplements under the Health Supplements Guidelines administered by HSA. Purchasers in Singapore should verify the import compliance status for their intended use.

Q: Can this product be taken alongside prescription medications for osteoarthritis?
A: Glucosamine and chondroitin supplements may interact with anticoagulant medications such as warfarin. The Royal Australian College of General Practitioners (RACGP) guidelines for osteoarthritis management recommend consulting a healthcare practitioner before combining nutritional supplements with prescribed anti-inflammatory or anticoagulant therapy.

Q: What is OptiMSM and how does it support joint health?
A: OptiMSM is a patented, purified form of methylsulfonylmethane (MSM) manufactured by Bergstrom Nutrition using a multi-stage distillation process compliant with cGMP standards. MSM provides bioavailable sulfur, an essential component for the synthesis of glycosaminoglycans and collagen within articular cartilage. Published clinical trials in the International Journal of Orthopaedics have demonstrated that MSM supplementation at doses of 500 mg or above can reduce joint pain scores in osteoarthritis patients.